Shopping Cart
- Remove All
Your shopping cart is currently empty
LY223982 is an effective and selective LTB4 (leukotriene B4 receptor) antagonist that inhibits LTB4-induced neutrophil activation and transient leukopenia.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $42 | In Stock | |
| 5 mg | $98 | In Stock | |
| 10 mg | $147 | In Stock | |
| 25 mg | $268 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $108 | In Stock |
| Description | LY223982 is an effective and selective LTB4 (leukotriene B4 receptor) antagonist that inhibits LTB4-induced neutrophil activation and transient leukopenia. |
| Targets&IC50 | LTB4:13.2 nM |
| In vitro | LY223982 is 189-fold more efficient than 35S-N-formyl-L-formyl-L-leucyl-L-phenylalanine (FMLP) in displacing [3H]LTB4 from its corresponding receptor on human neutrophils. The concentration that inhibits [3H]LTB4 displacement by 50% (IC50 value of 13.2 nM) is only 6.8-fold higher than that of non-radioactive LTB4.[1] |
| In vivo | LY223982 inhibits transient leukopenia induced by LTB4 (ED50, 3 mg/kg) in rabbits, but not by FMLP. LY223982 has no agonist activity in any test system.[1] |
| Synonyms | SKF107324, LY-223982, CGS23131 |
| Molecular Weight | 502.56 |
| Formula | C30H30O7 |
| Cas No. | 117423-74-2 |
| Smiles | C(CC(O)=O)C1=C(OCCCC/C=C/C2=CC=C(OC)C=C2)C=CC(C(=O)C3=CC(C(O)=O)=CC=C3)=C1 |
| Relative Density. | 1.235 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80.00 mg/mL (159.18 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.